Halozyme Therapeutics shares owned by Greenwood Capital Associates
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Greenwood Capital Associates
from 13F filings
Historical chart of Greenwood Capital Associates investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Greenwood Capital Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Greenwood Capital Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $525k | 7.8k | 67.30 |
More positions owned by Greenwood Capital Associates
View all positions for Greenwood Capital Associates